Christopher LaRocca

Christopher LaRocca is an Assistant Professor at the University of Minnesota, affiliated with the departments of Surgery and Genetics. His research focuses on cancer viroimmunotherapy, particularly oncolytic adenoviruses for pancreatic, breast, and colorectal cancers. He collaborates with institutions including NIH, Mayo Clinic Rochester, and American College of Surgeons.

• Current projects include developing therapies for metastatic colorectal cancer and viroimmunotherapy for ER+ breast cancer.
• Recent publications highlight his work on viral vector engineering and adjuvant therapy optimization for gallbladder and breast cancers.